Home › Disturbo depressivo maggiore › Florida › Tampa
Studi clinici su Disturbo depressivo maggiore a Tampa, FL
17 studi su Disturbo depressivo maggiore cercano partecipanti presso sedi a Tampa e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
In reclutamentoFase 3
- IPTB Clinical Research, Tampa
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
In reclutamentoFase 3
- Psych Me Medical Research Inc, Tampa
- Interventional Psychiatry of Tampa Bay, Tampa
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
In reclutamentoFase 2
- K2 Medical Research - Tampa, Tampa
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
In reclutamentoFase 3
- Interventional Psychiatry of Tampa Bay, Tampa
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
In reclutamentoFase 3
- K2 Medical Research Tampa, Tampa
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
In reclutamentoFase 4
- Neurocrine Clinical Site, Tampa
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
In reclutamentoFase 2
- IPTB Clinical Research, Tampa
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
In reclutamentoFase 2
- Draig Clinical Site, Tampa
- Draig Clinical Site, Tampa
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
In reclutamento
- USF Health, Tampa
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
In reclutamentoFase 3
- Neurocrine Clinical Site, Tampa
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
In reclutamentoFase 3
- K2 Medical Research (Tampa), Tampa
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
In reclutamentoFase 3
- K2 Medical Research - Tampa, Tampa
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
In reclutamentoFase 3
- Neurocrine Clinical Site, Tampa
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
In reclutamentoFase 3
- Neurocrine Clinical Site, Tampa
- Neurocrine Clinical Site, Tampa
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
In reclutamentoFase 2
- University of South Florida, Psychiatry and Behavioral Neurosciences, Tampa
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
In reclutamentoFase 2
- Autobahn Site #148, Tampa
Study of ALTO-300 in MDD
In reclutamentoFase 2
- Site 221, Tampa
Studi su Disturbo depressivo maggiore in altre città
- New York City, NY37 studi
- Boston, MA31 studi
- Atlanta, GA25 studi
- Philadelphia, PA23 studi
- Orlando, FL19 studi
- Miami, FL18 studi
- Chicago, IL17 studi
- Houston, TX16 studi
- San Diego, CA16 studi
- Little Rock, AR14 studi
- Orange, CA13 studi
- Austin, TX13 studi
Altri studi a Tampa
- Cancro del polmone non a piccole cellule51 studi
- Cancro al seno43 studi
- Cancro (tutti i tipi)39 studi
- Cancro colorettale33 studi
- Cancro metastatico29 studi
- Cancro ai polmoni29 studi
- Leucemia mieloide acuta29 studi
- Cancro pancreatico26 studi
- Cancro ovarico21 studi
- Sindromi mielodisplastiche19 studi
- Melanoma19 studi
- Insufficienza cardiaca18 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.